Priority Date: 15.08.12 (US 201261683596P)

EXOSOME-BASED THERAPEUTICS AGAINST NEURODEGENERATIVE DISORDERS

  • Application ID: EP13829748
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

operating since 2003
Headquarter in Mannheim and 3 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 171 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 15.08.2012 - Priority Date (US 201261683596P)
  • 20.02.2014 - Publication A1 (WO2014028763)
  • 24.06.2015 - Publication A1 (EP2885414)

IPC Classification